Test Discontinuation Memorandum

Effective August 31, 2016, in a continuing effort to optimize our offerings, these changes will be made.

The following will be discontinued:

  • Counsyl Universal Carrier Panel (TC 1200)
  • Counsyl Prenatal Panel (TC 1201)
  • Counsyl Fundamental Panel (TC 1202)
  • Counsyl Fundamental Plus (TC 1203)
  • Counsyl ACMG ACOG Panel (TC 1209)
  • Counsyl Ashkenazi Jewish Panel (TC 1210)
  • Counsyl Fundamental Plus and Hb-Beta Chain-Related Hemoglobinopathy (TC 1212)
  • Counsyl Universal Plus (TC 1213)
  • Counsyl Universal Plus NGS (TC 1221)
  • Counsyl Universal Carrier Panel NGS (TC 1222)
  • Counsyl Prenatal Panel NGS (TC 1223)
  • Counsyl Fundamental Panel by NGS (TC 1224)
  • Counsyl Fundamental Plus – NGS (TC 1225)
  • Counsyl ACMG ACOG Panel NGS (TC 1226)
  • Counsyl Ashkenazi Jewish Panel NGS (TC 1227)
  • Counsyl Fundamental Plus and Hb-Beta Chain-Related Hemoglobinopathy NGS (TC 1228)

Alternative testing is available:

  • Geneaware Complete Female (TC 60101)
  • Geneaware Complete Male (TC 60106)
  • Geneaware Ashkenazi Jewish Female (TC 60201)
  • Geneaware Ashkenazi Jewish Male (TC 60206)
  • Geneaware ACMG/ACOG Female (TC 60301)
  • Geneaware ACMG/ACOG Male (TC 60306)
  • Geneaware Basic Female (TC 60401)
  • Geneaware Basic Male (TC 60406)
Previous Post
Test Discontinuation Memorandum
Next Post
Baylor Genetics Selects Edico Genome’s DRAGEN To Improve Turnaround Times